Last 12 months
Inside the activity.
0 purchase rows · 42 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 17 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 15, 2019 Filed Jan 17, 2019 00:09 UTC |
Londei MarcoChief Medical Officer
|
Exercise / conversionCommon Stock | 19,075 | $6.93 | $132,189.75 |
DisclosureSEC source: 0001209191-19-003996 · doc4.xml · nonDerivative · entry 2 Londei Marco · CIK 0001654500 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 14, 2019 Filed Jan 17, 2019 00:11 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001209191-19-003997 · doc4.xml · derivative · entry 4 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,284 Underlying: Common Stock · 40,000 shares Expires 2022-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. F5 · balance_after: In addition to the remaining options to purchase 89,284 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 705,554 shares of common stock, which options vest according to their terms, and (ii) 30,064 shares of common stock held directly. Read SEC document |
| January 14, 2019 Filed Jan 17, 2019 00:11 UTC |
Suria HamzaDirector · President, CEO
|
SaleCommon Stock | 12,240 | $71.10 | $870,304.39 |
DisclosureSEC source: 0001209191-19-003997 · doc4.xml · nonDerivative · entry 3 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,064 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.00 to $71.60 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 14, 2019 Filed Jan 17, 2019 00:11 UTC |
Suria HamzaDirector · President, CEO
|
SaleCommon Stock | 27,760 | $70.65 | $1,961,227.34 |
DisclosureSEC source: 0001209191-19-003997 · doc4.xml · nonDerivative · entry 2 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,304 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 14, 2019 Filed Jan 17, 2019 00:11 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionCommon Stock | 40,000 | $1.12 | $44,800.00 |
DisclosureSEC source: 0001209191-19-003997 · doc4.xml · nonDerivative · entry 1 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 26, 2018 Filed Jan 17, 2019 00:09 UTC |
Londei MarcoChief Medical Officer
|
GiftCommon Stock | 122,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-003996 · doc4.xml · nonDerivative · entry 1 Londei Marco · CIK 0001654500 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,377 F1 · shares: Represents the number of shares of Issuer's common stock that were donated as a charitable contribution. The reporting person does not exercise voting or dispositive powers, directly or indirectly, over the donated shares following this transfer. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 02:48 UTC |
Londei MarcoChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $6.93 | $0.00 |
DisclosureSEC source: 0001209191-18-063384 · doc4.xml · derivative · entry 8 Londei Marco · CIK 0001654500 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,223 Underlying: Common Stock · 22,000 shares Expires 2025-08-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the shares subject to the option on August 13, 2016, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. F8 · balance_after: In addition to the remaining options to purchase 80,283 shares of common stock as set forth in Table II, the Reporting Person also holds (i) 144,877 shares of common stock held directly; and (ii) additional options to purchase up to an aggregate of 138,000 shares of common stock, which options vest according to their terms. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 02:48 UTC |
Londei MarcoChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 8,048 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001209191-18-063384 · doc4.xml · derivative · entry 7 Londei Marco · CIK 0001654500 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,060 Underlying: Common Stock · 8,048 shares Expires 2024-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the shares subject to the option on October 24, 2015, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 02:48 UTC |
Londei MarcoChief Medical Officer
|
SaleCommon Stock | 6,741 | $68.47 | $461,577.84 |
DisclosureSEC source: 0001209191-18-063384 · doc4.xml · nonDerivative · entry 6 Londei Marco · CIK 0001654500 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,877 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.05 to $68.73 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 02:48 UTC |
Londei MarcoChief Medical Officer
|
SaleCommon Stock | 8,002 | $67.57 | $540,683.94 |
DisclosureSEC source: 0001209191-18-063384 · doc4.xml · nonDerivative · entry 5 Londei Marco · CIK 0001654500 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,618 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.02 to $68.01 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 02:48 UTC |
Londei MarcoChief Medical Officer
|
SaleCommon Stock | 3,185 | $66.38 | $211,416.16 |
DisclosureSEC source: 0001209191-18-063384 · doc4.xml · nonDerivative · entry 4 Londei Marco · CIK 0001654500 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,620 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.00 to $66.92 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 02:48 UTC |
Londei MarcoChief Medical Officer
|
SaleCommon Stock | 12,120 | $65.36 | $792,177.74 |
DisclosureSEC source: 0001209191-18-063384 · doc4.xml · nonDerivative · entry 3 Londei Marco · CIK 0001654500 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,805 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 02:48 UTC |
Londei MarcoChief Medical Officer
|
Exercise / conversionCommon Stock | 22,000 | $6.93 | $152,460.00 |
DisclosureSEC source: 0001209191-18-063384 · doc4.xml · nonDerivative · entry 2 Londei Marco · CIK 0001654500 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 02:48 UTC |
Londei MarcoChief Medical Officer
|
Exercise / conversionCommon Stock | 8,048 | $0.70 | $5,633.60 |
DisclosureSEC source: 0001209191-18-063384 · doc4.xml · nonDerivative · entry 1 Londei Marco · CIK 0001654500 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 14, 2018 Filed Dec 19, 2018 02:46 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 41,728 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001209191-18-063382 · doc4.xml · derivative · entry 5 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,284 Underlying: Common Stock · 41,728 shares Expires 2022-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. F6 · balance_after: In addition to the remaining options to purchase 129,284 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 705,554 shares of common stock, which options vest according to their terms, and (ii) 30,064 shares of common stock held directly. Read SEC document |
| December 14, 2018 Filed Dec 19, 2018 02:46 UTC |
Suria HamzaDirector · President, CEO
|
SaleCommon Stock | 7,800 | $70.51 | $549,978.78 |
DisclosureSEC source: 0001209191-18-063382 · doc4.xml · nonDerivative · entry 4 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,064 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.33 to $70.98 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 14, 2018 Filed Dec 19, 2018 02:46 UTC |
Suria HamzaDirector · President, CEO
|
SaleCommon Stock | 9,084 | $69.68 | $632,967.67 |
DisclosureSEC source: 0001209191-18-063382 · doc4.xml · nonDerivative · entry 3 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,864 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.31 to $70.30 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 14, 2018 Filed Dec 19, 2018 02:46 UTC |
Suria HamzaDirector · President, CEO
|
SaleCommon Stock | 24,844 | $68.89 | $1,711,428.63 |
DisclosureSEC source: 0001209191-18-063382 · doc4.xml · nonDerivative · entry 2 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,948 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.31 to $69.30 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 14, 2018 Filed Dec 19, 2018 02:46 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionCommon Stock | 41,728 | $1.12 | $46,735.36 |
DisclosureSEC source: 0001209191-18-063382 · doc4.xml · nonDerivative · entry 1 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 12, 2018 Filed Dec 13, 2018 01:06 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionEmployee Stock Option · Derivative | 30,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001209191-18-062336 · doc4.xml · derivative · entry 11 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,361 Underlying: Common Stock · 30,000 shares Expires 2021-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F8 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. F9 · balance_after: In addition to the remaining options to purchase 80,361 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 796,205 shares of common stock, which options vest according to their terms, and (ii) 30,064 shares of common stock held directly. Read SEC document |
| December 12, 2018 Filed Dec 13, 2018 01:06 UTC |
Suria HamzaDirector · President, CEO
|
SaleCommon Stock | 8,324 | $72.88 | $606,618.16 |
DisclosureSEC source: 0001209191-18-062336 · doc4.xml · nonDerivative · entry 9 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,064 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.52 to $73.04 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 12, 2018 Filed Dec 13, 2018 01:06 UTC |
Suria HamzaDirector · President, CEO
|
SaleCommon Stock | 9,673 | $71.92 | $695,717.95 |
DisclosureSEC source: 0001209191-18-062336 · doc4.xml · nonDerivative · entry 8 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,388 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.51 to $72.48 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 12, 2018 Filed Dec 13, 2018 01:06 UTC |
Suria HamzaDirector · President, CEO
|
SaleCommon Stock | 12,003 | $71.11 | $853,480.52 |
DisclosureSEC source: 0001209191-18-062336 · doc4.xml · nonDerivative · entry 7 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,061 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.51 to $71.49 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 12, 2018 Filed Dec 13, 2018 01:06 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionCommon Stock | 30,000 | $1.12 | $33,600.00 |
DisclosureSEC source: 0001209191-18-062336 · doc4.xml · nonDerivative · entry 6 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 11, 2018 Filed Dec 13, 2018 01:06 UTC |
Suria HamzaDirector · President, CEO
|
SaleCommon Stock | 4,998 | $70.83 | $354,008.34 |
DisclosureSEC source: 0001209191-18-062336 · doc4.xml · nonDerivative · entry 5 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,064 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 10, 2018 Filed Dec 13, 2018 01:06 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 30,587 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001209191-18-062336 · doc4.xml · derivative · entry 10 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,361 Underlying: Common Stock · 30,587 shares Expires 2021-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F8 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. Read SEC document |
| December 10, 2018 Filed Dec 13, 2018 01:06 UTC |
Suria HamzaDirector · President, CEO
|
SaleCommon Stock | 4,964 | $72.48 | $359,805.12 |
DisclosureSEC source: 0001209191-18-062336 · doc4.xml · nonDerivative · entry 4 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,062 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.13 to $73.07 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 10, 2018 Filed Dec 13, 2018 01:06 UTC |
Suria HamzaDirector · President, CEO
|
SaleCommon Stock | 10,347 | $71.49 | $739,700.82 |
DisclosureSEC source: 0001209191-18-062336 · doc4.xml · nonDerivative · entry 3 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,026 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.01 to $71.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 10, 2018 Filed Dec 13, 2018 01:06 UTC |
Suria HamzaDirector · President, CEO
|
SaleCommon Stock | 15,276 | $70.57 | $1,078,082.31 |
DisclosureSEC source: 0001209191-18-062336 · doc4.xml · nonDerivative · entry 2 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,373 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.01 to $71.00 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 10, 2018 Filed Dec 13, 2018 01:06 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionCommon Stock | 30,587 | $1.12 | $34,257.44 |
DisclosureSEC source: 0001209191-18-062336 · doc4.xml · nonDerivative · entry 1 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 03, 2018 Filed Dec 5, 2018 02:33 UTC |
Piscitelli DominicChief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 37,000 | $0.00 Strike: $11.34 | $0.00 |
DisclosureSEC source: 0001209191-18-061100 · doc4.xml · derivative · entry 8 Piscitelli Dominic · CIK 0001695028 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,241 Underlying: Common Stock · 37,000 shares Expires 2027-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F8 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on January 9, 2018, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. F9 · balance_after: In addition to the remaining options to purchase 133,241 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 98,000 shares of common stock, which options vest according to their terms. Read SEC document |
| December 03, 2018 Filed Dec 5, 2018 02:33 UTC |
Piscitelli DominicChief Financial Officer
|
SaleCommon Stock | 1,100 | $75.81 | $83,390.01 |
DisclosureSEC source: 0001209191-18-061100 · doc4.xml · nonDerivative · entry 7 Piscitelli Dominic · CIK 0001695028 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.44 to $76.26 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 03, 2018 Filed Dec 5, 2018 02:33 UTC |
Piscitelli DominicChief Financial Officer
|
SaleCommon Stock | 6,624 | $74.33 | $492,361.92 |
DisclosureSEC source: 0001209191-18-061100 · doc4.xml · nonDerivative · entry 6 Piscitelli Dominic · CIK 0001695028 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.00 to $74.95 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 03, 2018 Filed Dec 5, 2018 02:33 UTC |
Piscitelli DominicChief Financial Officer
|
SaleCommon Stock | 2,298 | $73.18 | $168,158.68 |
DisclosureSEC source: 0001209191-18-061100 · doc4.xml · nonDerivative · entry 5 Piscitelli Dominic · CIK 0001695028 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,724 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.93 to $73.28 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 03, 2018 Filed Dec 5, 2018 02:33 UTC |
Piscitelli DominicChief Financial Officer
|
SaleCommon Stock | 4,820 | $72.24 | $348,212.22 |
DisclosureSEC source: 0001209191-18-061100 · doc4.xml · nonDerivative · entry 4 Piscitelli Dominic · CIK 0001695028 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,022 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.91 to $72.90 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 03, 2018 Filed Dec 5, 2018 02:33 UTC |
Piscitelli DominicChief Financial Officer
|
SaleCommon Stock | 18,604 | $71.33 | $1,327,060.53 |
DisclosureSEC source: 0001209191-18-061100 · doc4.xml · nonDerivative · entry 3 Piscitelli Dominic · CIK 0001695028 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,842 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.90 to $71.88 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 03, 2018 Filed Dec 5, 2018 02:33 UTC |
Piscitelli DominicChief Financial Officer
|
SaleCommon Stock | 3,554 | $70.34 | $249,974.14 |
DisclosureSEC source: 0001209191-18-061100 · doc4.xml · nonDerivative · entry 2 Piscitelli Dominic · CIK 0001695028 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,446 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.90 to $70.86 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 03, 2018 Filed Dec 5, 2018 02:33 UTC |
Piscitelli DominicChief Financial Officer
|
Exercise / conversionCommon Stock | 37,000 | $11.34 | $419,580.00 |
DisclosureSEC source: 0001209191-18-061100 · doc4.xml · nonDerivative · entry 1 Piscitelli Dominic · CIK 0001695028 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 07, 2018 Filed Sep 10, 2018 23:06 UTC |
Londei MarcoChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 142,857 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001209191-18-050362 · doc4.xml · derivative · entry 2 Londei Marco · CIK 0001654500 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,108 Underlying: Common Stock · 142,857 shares Expires 2024-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the shares subject to the option on October 24, 2015, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| September 07, 2018 Filed Sep 10, 2018 23:06 UTC |
Londei MarcoChief Medical Officer
|
Exercise / conversionCommon Stock | 142,857 | $0.70 | $99,999.90 |
DisclosureSEC source: 0001209191-18-050362 · doc4.xml · nonDerivative · entry 1 Londei Marco · CIK 0001654500 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,877 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2018 Filed Aug 8, 2018 17:56 UTC |
LOUMEAU ERIC JGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $78.18 | $0.00 |
DisclosureSEC source: 0001209191-18-045892 · doc4.xml · derivative · entry 1 LOUMEAU ERIC J · CIK 0001239648 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-08-05 F1 · derivative.exercise_date: The option vests over a 4 year period: 25% vest and become exercisable on August 6, 2019, after which 1/48th of the total shares vest and become exercisable monthly thereafter, subject to reporting person's continuous service through each vesting date. Read SEC document |
| July 09, 2018 Filed Jul 11, 2018 21:09 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,208 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001209191-18-042363 · doc4.xml · derivative · entry 4 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,208 shares Expires 2021-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. Read SEC document |
| July 09, 2018 Filed Jul 11, 2018 21:09 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,428 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001209191-18-042363 · doc4.xml · derivative · entry 3 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,428 shares Expires 2020-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. Read SEC document |
| July 09, 2018 Filed Jul 11, 2018 21:09 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionCommon Stock | 6,208 | $1.61 | $9,994.88 |
DisclosureSEC source: 0001209191-18-042363 · doc4.xml · nonDerivative · entry 2 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,062 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 09, 2018 Filed Jul 11, 2018 21:09 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionCommon Stock | 1,428 | $2.24 | $3,198.72 |
DisclosureSEC source: 0001209191-18-042363 · doc4.xml · nonDerivative · entry 1 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2018 Filed Jun 11, 2018 20:38 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 22,428 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-18-036984 · doc4.xml · derivative · entry 2 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,428 shares Expires 2018-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. Read SEC document |
| June 08, 2018 Filed Jun 11, 2018 20:38 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionCommon Stock | 22,428 | $2.59 | $58,088.52 |
DisclosureSEC source: 0001209191-18-036984 · doc4.xml · nonDerivative · entry 1 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2018 Filed May 15, 2018 18:25 UTC |
Frazier Healthcare VII, L.P.10% owner
Frazier Healthcare VII-A, L.P.10% owner
FHM VII, L.P.10% owner
FHM VII, L.L.C.10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
OtherCommon Stock | 1,372,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-18-000437 · edgar.xml · nonDerivative · entry 1 Frazier Healthcare VII, L.P. · CIK 0001553071 · 10% owner Frazier Healthcare VII-A, L.P. · CIK 0001575192 · 10% owner FHM VII, L.P. · CIK 0001654632 · 10% owner FHM VII, L.L.C. · CIK 0001654631 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 973,612 F1 · kind: Effective May 11, 2018, Frazier Healthcare V, L.P., distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners. The remaining securities are held by Frazier Healthcare V, L.P. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F1 · ownership.nature: Effective May 11, 2018, Frazier Healthcare V, L.P., distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners. The remaining securities are held by Frazier Healthcare V, L.P. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| May 11, 2018 Filed May 15, 2018 18:25 UTC |
Frazier Healthcare V, LP10% owner
FHM V, LP10% owner
FHM V, LLC10% owner
FRAZIER ALAN D10% owner
Naini Nader J10% owner
Every Nathan R10% owner
Heron Patrick J10% owner
|
OtherCommon Stock | 1,372,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-18-000436 · edgar.xml · nonDerivative · entry 1 Frazier Healthcare V, LP · CIK 0001341169 · 10% owner FHM V, LP · CIK 0001346948 · 10% owner FHM V, LLC · CIK 0001346944 · 10% owner FRAZIER ALAN D · CIK 0001018534 · 10% owner Naini Nader J · CIK 0001344203 · 10% owner Every Nathan R · CIK 0001531105 · 10% owner Heron Patrick J · CIK 0001365617 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 973,612 F1 · kind: Effective May 11, 2018, Frazier Healthcare V, L.P., distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners. The remaining securities are held by Frazier Healthcare V, L.P. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. F1 · ownership.direct: Effective May 11, 2018, Frazier Healthcare V, L.P., distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners. The remaining securities are held by Frazier Healthcare V, L.P. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any. Read SEC document |
| May 11, 2018 Filed May 15, 2018 22:26 UTC |
Topper James NDirector
|
OtherCommon Stock | 31,854 | $0.00 | $0.00 |
DisclosureSEC source: 0001012975-18-000438 · edgar.xml · nonDerivative · entry 4 Topper James N · CIK 0001341382 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,854 F4 · kind: Shares acquired by Dr. Topper through a distribution in-kind from FHM V, L.P. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.